{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:16:18Z","timestamp":1794572178466,"version":"4.9.1"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>One-quarter of US women who are at risk for cervical cancer delay screening. Self-collected (SC) cervical screening was recently US Food and Drug Administration (FDA)\u2013approved in the US for use in a health care setting only; an at-home SC option is crucial to address clinic-related barriers to screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To clinically validate the use of an SC device that was designed for optimal at-home performance, safety, ease-of-use, and dry storage and transport.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This nonrandomized clinical trial used a prospective method comparison study design. Participants aged 25 to 65 years were recruited from 16 clinical sites in the US including community and academic practices from November 20, 2023, to April 5, 2024. Data analysis was conducted from April to August 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Eligible participants collected a sample with the SC method, followed by a clinician-collected (CC) sample. The SC sample was eluted into PreservCyt at the laboratory and both samples were tested on an FDA-approved high risk human papillomavirus (hrHPV) test approved for primary screening. Participants were followed up for safety and completed usability and screening preference surveys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome and Measures<\/jats:title>\n                    <jats:p>The primary outcome measures were positive percentage agreement (PPA) and negative percentage agreement for detection of hrHPV between the SC and CC samples. Other study measures included clinical sensitivity for high grade cervical dysplasia and usability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 609 screening-eligible participants, 599 (262 aged 30-39 years [43.7%]; 583 identified as female [97.3%]) had paired SC-CC samples, of which 582 had valid paired samples included in the end point analysis. Among the 582 evaluable paired samples, the PPA between SC compared with paired CC samples for detection of hrHPV was 95.2% (95% CI, 92.1%-97.1%; 278 of 292 participants). The absolute clinical sensitivity for detection of high-grade cervical dysplasia was 95.8% (95% CI, 86.0%-98.8%; 46 of 48 participants), equivalent to the CC (relative sensitivity, 1.00). Nearly all participants (555 of 601 participants [92.3%]) reported that the device instructions were easy or very easy to understand and also that they would choose SC if they knew the results were comparable to CC results (560 of 602 participants [93.0%]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this nonrandomized clinical trial, SC samples collected with the device showed equivalent clinical sensitivity and exceeded the PPA end point for cervical screening. This SC method was found to be easy to use and to be a preferred option with high clinical performance intended for use in an at-home setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT06120205?cond=NCT06120205&amp;amp;amp;rank=1\">NCT06120205<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.11081","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:31:28Z","timestamp":1747654288000},"page":"e2511081","source":"Crossref","is-referenced-by-count":26,"title":["Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use"],"prefix":"10.1001","volume":"8","author":[{"given":"Megan B.","family":"Fitzpatrick","sequence":"first","affiliation":[{"name":"Teal Health, Inc., San Francisco, California"},{"name":"University of Wisconsin Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Behrens","sequence":"additional","affiliation":[{"name":"Independent consultant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Hibler","sequence":"additional","affiliation":[{"name":"Independent consultant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Parsons","sequence":"additional","affiliation":[{"name":"Teal Health, Inc., San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Planned Parenthood Southern New England, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Orso","sequence":"additional","affiliation":[{"name":"Alabama Clinical Therapeutics, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamar","family":"Parker","sequence":"additional","affiliation":[{"name":"Unified Women\u2019s Clinical Research, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Memmel","sequence":"additional","affiliation":[{"name":"Planned Parenthood Northern California, Concord"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Collins","sequence":"additional","affiliation":[{"name":"Centre for Obstetrics and Gynecology, Unified Woman\u2019s Clinical Research, Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"McNicholas","sequence":"additional","affiliation":[{"name":"Planned Parenthood Great Rivers, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaShonda","family":"Crane","sequence":"additional","affiliation":[{"name":"Planned Parenthood Gulf Coast, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Hwang","sequence":"additional","affiliation":[{"name":"Planned Parenthood League of Massachusetts, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Sutton","sequence":"additional","affiliation":[{"name":"Woman\u2019s Hospital Research Center, Woman\u2019s Hospital, Baton Rouge, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenell","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Kuroki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Harshberger","sequence":"additional","affiliation":[{"name":"Planned Parenthood Arizona, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Williams","sequence":"additional","affiliation":[{"name":"Planned Parenthood Arizona, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Jennings","sequence":"additional","affiliation":[{"name":"University of Wisconsin Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Buccini","sequence":"additional","affiliation":[{"name":"BioReference Health, Elmwood Park, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gillis","sequence":"additional","affiliation":[{"name":"NxGen BioStats, LLC, Mount Airy, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiva P.","family":"Novetsky","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Westchester Medical Center, Westchester County, New York"},{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York Medical College, Valhalla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hawkes","sequence":"additional","affiliation":[{"name":"Australian Centre for the Prevention of Cervical Cancer, Melbourne, Victoria, Australia"},{"name":"Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[{"name":"Australian Centre for the Prevention of Cervical Cancer, Melbourne, Victoria, Australia"},{"name":"Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trena","family":"Depel","sequence":"additional","affiliation":[{"name":"Teal Health, Inc., San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Aviki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York University Langone Health, Mineola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangini S.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Specialties, Smilow Comprehensive Cancer Center, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Conageski","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"7","key":"zoi250385r1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"zoi250385r2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"1","key":"zoi250385r3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer.","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"zoi250385r4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/LGT.0000000000000614","article-title":"The ASCCP cervical cancer screening task force endorsement and opinion on the American Cancer Society updated cervical cancer screening guidelines.","volume":"25","author":"Marcus","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"zoi250385r5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi250385r6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"10","key":"zoi250385r9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274974","article-title":"Racial and ethnic differences in cervical cancer screening barriers and intentions: the my body my test-3 HPV self-collection trial among under-screened, low-income women.","volume":"17","author":"Zeno","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"zoi250385r10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.43582","article-title":"Assessment of US Preventive Services Task Force guideline-concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019.","volume":"5","author":"Suk","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi250385r11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/ijgc-2022-003728","article-title":"The increasing incidence of stage IV cervical cancer in the USA: what factors are related?","volume":"32","author":"Francoeur","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"zoi250385r12","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"zoi250385r13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.33967","article-title":"Meta-analysis of agreement\/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening.","volume":"151","author":"Arbyn","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"zoi250385r14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12885-017-3723-5","article-title":"Barriers to HPV self-sampling and cytology among low-income Indigenous women in rural areas of a middle-income setting: a qualitative study.","volume":"17","author":"Allen-Leigh","year":"2017","journal-title":"BMC Cancer"},{"issue":"7","key":"zoi250385r15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181905","article-title":"Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay.","volume":"12","author":"Catarino","year":"2017","journal-title":"PLoS One"},{"key":"zoi250385r16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104375","article-title":"Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study.","volume":"127","author":"Saville","year":"2020","journal-title":"J Clin Virol"},{"key":"zoi250385r17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcv.2016.04.012","article-title":"Comparison of dry and wet vaginal swabs with cervical specimens in Roche Cobas 4800 HPV and Abbott RealTime high risk HPV tests.","volume":"79","author":"Jun","year":"2016","journal-title":"J Clin Virol"},{"issue":"11","key":"zoi250385r18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14729","article-title":"Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial.","volume":"2","author":"Winer","year":"2019","journal-title":"JAMA Netw Open"},{"key":"zoi250385r19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pvr.2018.04.005","article-title":"Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening.","volume":"5","author":"Ejegod","year":"2018","journal-title":"Papillomavirus Res"},{"key":"zoi250385r20","article-title":"Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.","volume":"11","author":"Inturrisi","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"20","key":"zoi250385r21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"zoi250385r25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"zoi250385r26","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.03386-12","article-title":"Development and characterization of the cobas human papillomavirus test.","volume":"51","author":"Rao","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"9916","key":"zoi250385r27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"zoi250385r28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity human papillomavirus trial: design, methods, and baseline results.","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"6","key":"zoi250385r29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"zoi250385r30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s10903-014-0125-5","article-title":"Feasibility of cervical cancer screening utilizing self-sample human papillomavirus testing among Mexican immigrant women in Harris County, Texas: a pilot study.","volume":"17","author":"Montealegre","year":"2015","journal-title":"J Immigr Minor Health"},{"issue":"4","key":"zoi250385r31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10552-019-01145-7","article-title":"\u201cMy husband says this: If you are alive, you can be someone\u2026\u201d: facilitators and barriers to cervical cancer screening among women living with HIV in India.","volume":"30","author":"Kung","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"2","key":"zoi250385r32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/S0036-36342013000200007","article-title":"HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile.","volume":"55","author":"L\u00e9niz","year":"2013","journal-title":"Salud Publica Mex"},{"issue":"1","key":"zoi250385r33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228042","article-title":"Implementation of Australia\u2019s renewed cervical screening program: preparedness of general practitioners and nurses.","volume":"15","author":"Sultana","year":"2020","journal-title":"PLoS One"},{"key":"zoi250385r34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpubh.2018.00077","article-title":"Self-sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs.","volume":"6","author":"Gupta","year":"2018","journal-title":"Front Public Health"},{"issue":"4","key":"zoi250385r35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151978","article-title":"Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme.","volume":"11","author":"Enerly","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"zoi250385r36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/bjc.2015.11","article-title":"Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.","volume":"112","author":"Giorgi Rossi","year":"2015","journal-title":"Br J Cancer"},{"issue":"5","key":"zoi250385r37","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ijc.26128","article-title":"Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.","volume":"130","author":"G\u00f6k","year":"2012","journal-title":"Int J Cancer"},{"key":"zoi250385r38","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.","volume":"340","author":"G\u00f6k","year":"2010","journal-title":"BMJ"},{"issue":"9","key":"zoi250385r39","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.3390\/curroncol31090399","article-title":"Self-screening for cervical cancer offered through a digital platform in a region of British Columbia with lower screening rates.","volume":"31","author":"Smith","year":"2024","journal-title":"Curr Oncol"},{"issue":"4","key":"zoi250385r41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10900-017-0316-9","article-title":"Cervical cancer screening barriers and risk factor knowledge among uninsured women.","volume":"42","author":"Akinlotan","year":"2017","journal-title":"J Community Health"},{"issue":"11","key":"zoi250385r42","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41416-024-02681-z","article-title":"Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.","volume":"130","author":"Rebolj","year":"2024","journal-title":"Br J Cancer"},{"issue":"6","key":"zoi250385r43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15490","article-title":"Changes in cancer screening in the US During the COVID-19 Pandemic.","volume":"5","author":"Fedewa","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi250385r44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2147\/IJWH.S288376","article-title":"Cervical cancer screening postpandemic: self-sampling opportunities to accelerate the elimination of cervical cancer.","volume":"13","author":"Lozar","year":"2021","journal-title":"Int J Womens Health"},{"key":"zoi250385r45","article-title":"Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in federally qualified health centers: a mixed methods study.","volume":"12","author":"Fuzzell","year":"2023","journal-title":"Elife"},{"issue":"5","key":"zoi250385r47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1377\/hlthaff.2021.01706","article-title":"Medicare beneficiaries in disadvantaged neighborhoods increased telemedicine use during the COVID-19 pandemic.","volume":"41","author":"Bose","year":"2022","journal-title":"Health Aff (Millwood)"},{"issue":"8","key":"zoi250385r48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1089\/tmj.2020.0525","article-title":"The impact of telehealth implementation on underserved populations and no-show rates by medical specialty during the COVID-19 pandemic.","volume":"27","author":"Franciosi","year":"2021","journal-title":"Telemed J E Health"},{"key":"zoi250385r49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.preghy.2018.12.007","article-title":"Telehealth with remote blood pressure monitoring for postpartum hypertension: a prospective single-cohort feasibility study.","volume":"15","author":"Hoppe","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"zoi250385r51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.NPR.0000742912.87293.02","article-title":"The role of telemedicine in gynecologic healthcare: a narrative review.","volume":"46","author":"Weltin","year":"2021","journal-title":"Nurse Pract"},{"issue":"4","key":"zoi250385r53","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S2468-2667(20)30006-2","article-title":"Projected time to elimination of cervical cancer in the USA: a comparative modelling study.","volume":"5","author":"Burger","year":"2020","journal-title":"Lancet Public Health"},{"issue":"6","key":"zoi250385r54","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.15321","article-title":"Modeling cervical cancer screening strategies with varying levels of human papillomavirus vaccination.","volume":"4","author":"Grimes","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi250385r55","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ijc.28545","article-title":"Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.","volume":"134","author":"Broberg","year":"2014","journal-title":"Int J Cancer"},{"issue":"6","key":"zoi250385r56","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2468-2667(23)00076-2","article-title":"Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.","volume":"8","author":"Pretsch","year":"2023","journal-title":"Lancet Public Health"},{"issue":"1","key":"zoi250385r57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/LGT.0000000000000051","article-title":"Feasibility of at-home self-sampling for HPV testing as an appropriate screening strategy for nonparticipants in Switzerland: preliminary results of the DEPIST study.","volume":"19","author":"Catarino","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"zoi250385r22","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","author":"Nayer","year":"2015","edition":"3rd ed"},{"key":"zoi250385r7","unstructured":"United States Preventive Services Taskforce. Draft evidence review\u2014cervical cancer: screening. Published December 10, 2024. Accessed April 14, 2025. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/document\/draft-evidence-review\/cervical-cancer-screening-adults-adolescents"},{"key":"zoi250385r8","unstructured":"Healthy People 2030. Increase the proportion of females who get screened for cervical cancer\u2014C-09. Office of Disease Prevention and Health Promotion. Accessed April 14, 2025. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/cancer\/increase-proportion-females-who-get-screened-cervical-cancer-c-09"},{"key":"zoi250385r23","unstructured":"Department of Health and Human Services. Collection of race and ethnicity data in clinical trials: guidance for Food and Drug Administration staff. Published October 26, 2016. Accessed April 18, 2025. https:\/\/www.fda.gov\/media\/75453\/download"},{"key":"zoi250385r24","unstructured":"US. Food and Drug Administration. Summary Of safety and effectiveness data (SSED). Published May 14, 2024. Accessed April 14, 2025. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/P190028S009B.pdf?"},{"key":"zoi250385r40","unstructured":"Mast? C, Munoz del Rio? A. Delayed cancer screenings\u2014a second look. Epic Research. Published July 17, 2020. Accessed April 14, 2025. https:\/\/www.epicresearch.org\/articles\/delayed-cancer-screenings-a-second-look\/"},{"key":"zoi250385r46","unstructured":"Winstead? E. For cancer screening, COVID-19 pandemic creates obstacles, opportunities. National Cancer Institute. Published March 10, 2021. Accessed April 14, 2025. https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2021\/cancer-screening-decreases-coronavirus-pandemic"},{"key":"zoi250385r50","unstructured":"Bestsennyy? O, Gilbert? G, Harris? A, Rost? J. Telehealth: a quarter-trillion-dollar post-COVID-19 reality? McKinsey. Published July 9, 2021. Accessed April 14, 2025. https:\/\/www.mckinsey.com\/industries\/healthcare-systems-and-services\/our-insights\/telehealth-a-quarter-trillion-dollar-post-covid-19-reality#"},{"key":"zoi250385r52","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Published November 17, 2020. Accessed April 14, 2025. https:\/\/www.who.int\/publications-detail-redirect\/9789240014107"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834245\/fitzpatrick_2025_oi_250385_1747078183.99715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:31:38Z","timestamp":1747654298000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834245"}},"subtitle":["A Nonrandomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.11081","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}